We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Life Sciences

Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.



Sign up for a 7-day FREE trial today!



Latest News in Life Sciences

  • October 22, 2018

    Landmark Roundup Verdict Survives, But Cut Down By $211M

    A California judge on Monday slashed roughly $211 million from the $289 million jury verdict won by a groundskeeper who alleged that Monsanto’s Roundup weedkiller caused his lymphoma, ruling that the jury’s punitive damages award must be limited to protect the agrochemical giant’s due process rights.

  • October 22, 2018

    Fed. Circ. Rejects Bid For PTAB Tribal Immunity Rehearing

    The full Federal Circuit on Monday said it won't reconsider a panel’s ruling that tribes can face Patent Trial and Appeal Board scrutiny, likely paving the way for one of the court’s closest-watched cases to head to the U.S. Supreme Court.

  • October 22, 2018

    Medical Co. Inks $5.25M Deal To End FCA Accusations

    A Kentucky-based medical equipment company will pony up more than $5.25 million to end accusations that it made false statements about the contents of its compounded medical creams, the federal government announced on Monday.

  • October 22, 2018

    Labs Say UnitedHealth Can't Sue On State Fraud Claims

    A group of medical testing labs urged a Texas federal judge Friday to toss a $44 million suit brought by UnitedHealthcare Insurance Co., saying payments made by the insurer weren't fraudulent and were federally mandated through the Employee Retirement Income Security Act.

  • October 22, 2018

    Desmarais Adds Ex-Sidley Pair As Life Science Partners

    Desmarais LLP has added as partners in its life sciences practice a pair of experienced attorneys from Sidley Austin with a specialty in representing pharmaceutical patent holders in Hatch-Waxman Act cases, the firm has announced.

See more Life Sciences news

Life Sciences

Areas of Coverage

  • AGENCIES
  • U.S. Consumer Product Safety Commission
  • U.S. Food and Drug Administration
  • U.S. Patent and Trademark Office
  • U.S. International Trade Commission
  • POLICY & REGULATION
  • Affordable Care Act
  • Federal Food, Drug, and Cosmetic Act
  • Antitrust and consumer protection controls
  • Drug and medical device lobbying
  • State and international life sciences legislation and regulation
  • ENFORCEMENT
  • Drug and medical device recalls
  • Drug safety actions
  • Pay-for-delay investigations
  • Merger reviews
  • LITIGATION
  • Patent disputes, including
  • Abbreviated New Drug Application litigation
  • Section 301 cases
  • Product safety suits over drugs and medical devices, including off-label marketing and failure-to-warn claims
  • Consumer litigation and class actions
  • Fraud and compliance suits
  • Antitrust disputes
  • Labor and employment suits
  • Shareholder and corporate governance disputes
  • Bankruptcy proceedings
  • TRANSACTIONS
  • Mergers, acquisitions, and joint ventures
  • Share buybacks and stock splits
  • Private equity deals
  • Patent-licensing agreements
  • PROFILES
  • Personnel moves
  • Profiles of life sciences practice groups

Readership

  • Life sciences lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the drug, biotechnology, and medical device industries
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals